Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Jun 5, 2026 · Filed Jun 6, 2026
Equillium's President and CSO sold $91K of Equillium shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$91,070
Shares × reported transaction price
23 days after results of May 13, 2026, 69 days before results of Aug 13, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +1.1% | +2.1% | −1.0% |
| 30 days | +13.7% | +0.8% | +12.9% |
| 90 days | −13.0% | +3.6% | −16.6% |
Past results only. Not a forecast.
Insider filing
Traded Jun 5 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Christine Zedelmayer (Sr. Vice President and COO) sold ~$43K of Equillium
Planned saleInsider filing
Traded Jun 5 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
